Company news
Waldencast Plc (NASDAQ:WALD) news
Every Waldencast Plc press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act
September 14, 2026
Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
July 30, 2026
Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
June 15, 2026
Waldencast Announces Sale of Obagi Medical to Bridgepoint
June 1, 2026
Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting
May 15, 2026
Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*
April 30, 2026
Waldencast announces conclusion of SEC investigation
April 28, 2026
Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthfulness
March 24, 2026
Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™
March 19, 2026
Waldencast Reports Q4 2025 and FY 2025 Financial Results
March 13, 2026
Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date
March 11, 2026
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 27, 2026
Obagi Medical and It’s a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 25, 2026
Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 17, 2026
Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 6, 2026
Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 5, 2026
Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect
February 3, 2026
Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
January 30, 2026
Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
January 28, 2026
UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
January 27, 2026
Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
January 27, 2026
Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
January 26, 2026
CORRECTION – Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
January 26, 2026
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler
January 21, 2026
Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update
November 24, 2025
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
November 16, 2025
Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities
November 14, 2025
Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates
November 12, 2025
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum
October 8, 2025
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
September 10, 2025
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation
August 18, 2025
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
July 23, 2025
Waldencast Reports Q1 2025 Financial Results
May 13, 2025
Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast
May 6, 2025
Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream
April 22, 2025
Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results
March 18, 2025
Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast
March 11, 2025
Waldencast Announces Participation in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit
February 19, 2025
Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection
February 10, 2025
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates
January 30, 2025
Waldencast Announces Participation in the 2025 IMCAS World Congress
January 29, 2025
Milk Makeup to Launch at Ulta Beauty This Spring
January 28, 2025
Waldencast Announces Participation in the ICR Conference 2025
January 6, 2025
Waldencast Reports Q3 2024 Financial Results
November 20, 2024
Waldencast plc Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast
November 13, 2024
Waldencast plc Announces Board Appointments and Annual General Meeting
October 7, 2024
Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate
September 9, 2024
Waldencast Reports Q2 2024 Financial Results
August 27, 2024
Waldencast plc Provides Second Quarter and First Half Fiscal 2024 Earnings Conference Call and Webcast Information
August 21, 2024
Waldencast Announces Participation in the Canaccord Genuity 44th Annual Growth Conference
August 7, 2024